Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001062137 | SCV001226916 | pathogenic | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2019-12-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser586Cysfs*24) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100). This variant has not been reported in the literature in individuals with CDKL5-related conditions. This variant is not present in population databases (ExAC no frequency). |